Carregant...
Combination Immunotherapy for Type 1 Diabetes
PURPOSE OF REVIEW: Type 1 Diabetes (T1D) is an autoimmune disease marked by β-cell destruction. Immunotherapies for T1D have been investigated since the 1980s and have focused on restoration of tolerance, T-cell or B-cell inhibition, regulatory T-cell (Treg) induction, suppression of innate immunity...
Guardat en:
| Publicat a: | Curr Diab Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5774222/ https://ncbi.nlm.nih.gov/pubmed/28534310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-017-0878-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|